The United States Dialysis Market is anticipated to grow at a high rate, increasing from US$ 1.35 Billion in 2024 to US$ 1.96 Billion by 2033. The growth reflects a strong Compound Annual Growth Rate (CAGR) of 4.25% for the years 2025-2033. The reasons for this growth are rising cases of kidney diseases, improved dialysis technology, and an expanding aging population with renal needs.
With almost half a million patients on dialysis in the United States, the process is crucial in the treatment of kidney failure, enhancing quality of life, and eventually increasing patient survival rates.
Two primary forms of dialysis exist: hemodialysis and peritoneal dialysis. Hemodialysis cleans blood using a machine and returns the purified blood to the body, generally done in a clinic three or more times a week. Peritoneal dialysis uses the lining of the abdominal cavity to filter blood and provides more freedom for patients since it can be done at home in many cases.
The growing number of CKD and ESRD cases is the main driver of U.S. dialysis demand. Rising populations, increased prevalence of diabetes, hypertension, and obesity are the key factors that fuel kidney disease development. Over 1 in 7 US adults-approximately 35.5 million individuals, or 14%-are estimated to have CKD. Millions of Americans have CKD, and many of them eventually need transplantation or dialysis, the CDC states. Since kidney transplantation is limited by organ availability, dialysis emerges as the main life-sustaining therapy for the majority of patients. Such an increasing patient population provides steady demand for dialysis services, equipment, and supplies, making the U.S. dialysis market grow steadily year by year.
2. B. Braun Melsungen AG
3. Baxter International Inc.
4. Becton Dickinson and Company
5. DaVita Inc.
6. Fresenius Medical Care AG & Co. KGaA
7. JMS Co.Ltd.
8. Medtronic Plc.
United States Dialysis Market Outlook
Dialysis is a therapeutic process that acts as an alternative to the natural filtration activity of the kidneys. It consists of waste product and excess fluid removal from the blood when the kidneys are unable to perform these actions because of diseases like CKD or acute kidney injury. In the United States, dialysis is used mainly for end-stage renal disease (ESRD) patients and is their lifeline for staying healthy.With almost half a million patients on dialysis in the United States, the process is crucial in the treatment of kidney failure, enhancing quality of life, and eventually increasing patient survival rates.
Two primary forms of dialysis exist: hemodialysis and peritoneal dialysis. Hemodialysis cleans blood using a machine and returns the purified blood to the body, generally done in a clinic three or more times a week. Peritoneal dialysis uses the lining of the abdominal cavity to filter blood and provides more freedom for patients since it can be done at home in many cases.
Growth Drivers in the United States Dialysis Market
Increasing Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)The growing number of CKD and ESRD cases is the main driver of U.S. dialysis demand. Rising populations, increased prevalence of diabetes, hypertension, and obesity are the key factors that fuel kidney disease development. Over 1 in 7 US adults-approximately 35.5 million individuals, or 14%-are estimated to have CKD. Millions of Americans have CKD, and many of them eventually need transplantation or dialysis, the CDC states. Since kidney transplantation is limited by organ availability, dialysis emerges as the main life-sustaining therapy for the majority of patients. Such an increasing patient population provides steady demand for dialysis services, equipment, and supplies, making the U.S. dialysis market grow steadily year by year.
Advances in Dialysis Equipment and Technology
Technological innovation is revolutionizing the U.S. dialysis market through enhanced patient outcomes and comfort. Advanced hemodialysis equipment comes with real-time monitoring, sophisticated filtration, and tailored treatment settings. Wearable and portable dialysis devices in the pipeline offer enhanced flexibility for patients, enabling home care. Incorporation of telehealth platforms also optimizes remote monitoring and minimizes hospital visits. Developments in peritoneal dialysis fluids and biocompatible materials are enhancing safety and efficiency. These developments not only support patient compliance but also support adoption of home dialysis, alleviating in-center facility load. As technology improves, the market will be growing at a strong rate with enhanced care delivery. In a promising project that could revolutionize kidney dialysis, a team of researchers at UNC-Chapel Hill is working on developing a membrane technology that has the potential to significantly miniaturize equipment used in dialysis, aiming to bring convenient and effective treatment to millions of patients across the globe.Growth of Home Dialysis Programs and Reimbursement Support
A significant growth impetus is the increasing use of home dialysis, which is encouraged by government policies and positive reimbursement environments. The Centers for Medicare & Medicaid Services (CMS) has initiated programs that encourage home dialysis to enhance patient quality of life and curb long-term healthcare expenses. Home-based therapies like peritoneal dialysis and home hemodialysis provide patients with increased convenience and autonomy while reducing dependence on dialysis centers. Growing availability of training programs and supportive technologies is driving adoption. As policymakers are stressing value-based care, reimbursement support for home dialysis is gaining strength, cementing its position as a significant growth area in the U.S. market. Medicare Part B will reimburse 80% of home dialysis expenses. These include training, equipment, and supplies.Challenges in the United States Dialysis Market
High Treatment Costs and Economic Burden
Dialysis is also one of the most costly long-term care therapies in the United States. Treatment usually takes place several times a week, with each session demanding expensive machinery, materials, and professional services. Though Medicare insures the majority of patients with ESRD, out-of-pocket expenditures for supplemental charges are significant, creating financial pressure. Providers are also economically burdened since reimbursement payments might not be commensurate with increasing operating costs. The expense of setting up and running dialysis facilities further constrains development in medically underserved regions. Maintaining affordability, accessibility, and profitability is an ongoing issue, especially with growing demand for dialysis across the country.Workforce Gaps and Overload on Dialysis Facilities
Dialysis is a treatment that necessitates skilled nephrologists, nurses, and technicians, but the U.S. has a shortage of dedicated healthcare providers. Increased patient loads in current centers create higher workloads, which in turn cause staffing shortages and possible drops in the quality of care. Rural areas and underserved populations are especially vulnerable, having fewer dialysis centers and less availability of specialists. Staffing shortages also hinder the use of home dialysis, as proper training and continuing patient support are critical. Lacking adequate skilled staff, keeping up with growing demand becomes ever more challenging, posing systemic problems for both patients and providers throughout the U.S. dialysis industry.United States Peritoneal Dialysis Market
The peritoneal dialysis market in the U.S. is increasing as patients and providers become aware of its convenience and value compared to in-center hemodialysis. Peritoneal dialysis enables patients to conduct treatments at home, usually overnight, enhancing quality of life and lessening hospital attendance. Improvements in automated cycler machines and biocompatible dialysis solutions are key drivers. Another support from CMS and private insurers in the form of reimbursement incentives is also contributing towards market growth. Infections like peritonitis and training needs of patients are still challenges despite such supports. As patient care becomes more patient-centric, peritoneal dialysis continues to be an important segment of the U.S. dialysis market.United States Dialysis Services Market
U.S. dialysis market is based on dialysis services, which include both in-center hemodialysis and home-based therapies. Large players like DaVita and Fresenius dominate the market, providing end-to-end services through a large network of centers. Increasing prevalence of ESRD guarantees steady demand for the services, with reimbursement policies offering good financial backing. Service providers are also increasingly implementing telehealth for remote monitoring and widening patient education programs to enhance compliance. Although the industry is grappling with staffing and cost issues, ongoing investment in patient-related models and growth in home dialysis services assures long-term growth, resulting in services as the biggest revenue-generating segment.United States Dialysis Equipment Market
The United States dialysis equipment market is growing considerably, fueled by technological advancements and increased treatment needs. High-end hemodialysis units with improved monitoring systems, portable models for home use, and next-generation peritoneal dialysis cyclers are emerging as favorites. Demand also remains high for consumables such as dialyzers, tubing, and catheters, which are repeat purchase items. Top companies are heavily investing in R&D to enhance safety, minimize complications, and make patients more comfortable. Adoption of equipment is also being fueled by reimbursement schemes and hospitals renovating their buildings. With continuous innovation and an increasing number of patients, the U.S. dialysis equipment market will continue to remain strong.United States Home Dialysis Market
The U.S. home dialysis market is experiencing robust growth, driven by policies conducive to growth, patient preference, and technology development. Home modalities such as peritoneal dialysis and home hemodialysis provide patients with more independence, better quality of life, and reduced visits to dialysis centers. Government initiatives such as the "Advancing American Kidney Health" initiative are driving adoption at an accelerated rate through reimbursement incentives. Portable machines, remote monitoring technologies, and easy-to-use equipment improve safety and convenience. Nevertheless, training and continuous support are still essential for patients switching to home care. With healthcare moving in the direction of value-based models, home dialysis is increasingly becoming a crucial segment in the U.S. dialysis market.California Dialysis Market
California is one of the largest state markets for dialysis in the United States due to its large population, the high incidence of diabetes, and well-developed healthcare infrastructure. Large providers have large networks of dialysis facilities throughout the state that serve a wide range of patient needs. California is also a hotbed of innovation with high rates of adoption of home dialysis and new technology. But the state struggles with increasing healthcare expenses and providing access for the underserved population, especially in rural settings. Policy measures, such as Medicaid expansion, still fuel growth. Globally, California continues to be an important contributor to the country's dialysis market.New York Dialysis Market
The New York dialysis market is growing consistently, driven by a high incidence of chronic kidney disease as well as robust urban healthcare systems. The densely populated state generates considerable demand for in-center hemodialysis, with top players having several facilities. Home dialysis adoption is also increasing, particularly in cities where patients appreciate convenience and lower travel. Policies of reimbursement, such as Medicare and Medicaid assistance, are crucial to market expansion. Providers face the challenges of staffing shortages and operating costs that are high. In spite of these challenges, technological development and patient education programs are aiding in driving long-term New York dialysis growth.New Jersey Dialysis Market
The dialysis market of New Jersey is expanding as a result of its aging population and lifestyle-related diseases like diabetes and hypertension, which have high incidences. The state's proximity to larger medical centers in New York and Philadelphia enhances access to specialized dialysis technology and care. Both in-center and home dialysis are growing, with Medicare reimbursement and growing private insurer participation supporting both. Challenges include increasing healthcare costs and staff shortages. Improving patient education and availability of home dialysis programs are areas providers are addressing to meet demand. Thanks to its robust healthcare infrastructure, New Jersey continues to be a significant regional market for dialysis care.Market Segmentation
Type
- Peritoneal Dialysis
- Hemodialysis
Product & Services
- Services
- Equipment
- Consumables
- Drugs
End User
- Home Dialysis
- In Center Dialysis
Top States
- California
- Texas
- New York
- Florida
- Illinois
- Pennsylvania
- Ohio
- Georgia
- New Jersey
- Washington
- North Carolina
- Massachusetts
- Virginia
- Michigan
- Maryland
- Colorado
- Tennessee
- Indiana
- Arizona
- Minnesota
- Wisconsin
- Missouri
- Connecticut
- South Carolina
- Oregon
- Louisiana
- Alabama
- Kentucky
- Rest of United States
All companies have been covered with 5 Viewpoints
- Overviews
- Key Person
- Recent Developments
- SWOT Analysis
- Revenue Analysis
Key Players Analysis
1. Asahi Kasei Corporation2. B. Braun Melsungen AG
3. Baxter International Inc.
4. Becton Dickinson and Company
5. DaVita Inc.
6. Fresenius Medical Care AG & Co. KGaA
7. JMS Co.Ltd.
8. Medtronic Plc.
Table of Contents
1. Introduction3. Executive Summary11. Value Chain Analysis
2. Research & Methodology
4. Market Dynamics
5. United States Dialysis Market
6. Market Share Analysis
7. Type
8. Product & Services
9. End User
10. Top States
12. Porter's Five Forces Analysis
13. SWOT Analysis
14. Pricing Benchmark Analysis
15. Key Players Analysis
Companies Mentioned
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton Dickinson and Company
- DaVita Inc.
- Fresenius Medical Care AG & Co. KGaA
- JMS Co.Ltd.
- Medtronic Plc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 35.09 Billion |
| Forecasted Market Value ( USD | $ 50.86 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
